Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/PPB/TAI GUK IBUPROFEN TABLETS 200MG

Approved

STANDARD

TAI GUK IBUPROFEN TABLETS 200MG

WELL FAVOURED LIMITED🇰🇪 Pharmacy and Poisons Board

Approval Date: Jun 21, 2024
Approval ID: b16c80f3ab84909c
Company: WELL FAVOURED LIMITED
Type: Standard

Approval Details

Approval Id: b16c80f3ab84909c
Product Name: TAI GUK IBUPROFEN TABLETS 200MG
Drug Hk Name: TAI GUK IBUPROFEN TABLETS 200MG
Registration Code: HK-63935
Company Name: WELL FAVOURED LIMITED
Company Detail Path: /organization/well-favoured-limited
Registration Category: Part 1 Poison
Sale Requirement: Pharmacy only Medicines
Registration Date: 2015-09-07
Company Address: 9/F HENLEY CENTRE, 9-15 BUTE ST MONGKOK KLN

Active Ingredients

Approved

Quick Info

Agency

PPB

Country

🇰🇪

Approval Date

Jun 21, 2024

Approval ID

b16c80f3ab84909c

Type

Standard

Back to PPB Approvals

TAI GUK IBUPROFEN TABLETS 200MG - PPB Drug Approval Details